Australia markets closed

INOVIQ Ltd (IIQ.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.6100+0.0250 (+4.27%)
At close: 03:27PM AEDT
Full screen
Previous close0.5850
Open0.6000
Bid0.6000 x N/A
Ask0.6500 x N/A
Day's range0.6000 - 0.6250
52-week range0.4600 - 0.9900
Volume50,298
Avg. volume91,644
Market cap56.131M
Beta (5Y monthly)2.20
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    EXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TEST

    INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company), a developer of next-generation exosome solutions and precision diagnostics, is pleased to announce excellent results from an independent clinical validation study of its SubB2M/CA15-3 test for breast cancer detection. The study showed high accuracy (87%), sensitivity (81%), and specificity (93%) for INOVIQ's SubB2M test, outperforming a leading approved CA15-3 test.